Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06346483 · ClinicalTrials.gov registry record · NA

Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off

A NA study of Kidney Stone and Ureteral Stone, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06346483 is a NA study of Kidney Stone and Ureteral Stone that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 150 participants, below the 188-participant average among 28 other Kidney Stone trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06346483, a NA study of Kidney Stone and Ureteral Stone, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare Moses 2.0 pulse modulation technology and the standard high powered Holmium Laser lithotripsy and how it will affect time in the operating room, time using the laser, laser energy, and stone free rates. Currently Moses 2.0 laser technology is FDA approved and currently used in practice since 2021. No study to this date has compared Moses 2.0 without pulse modulation laser technology to Moses 2.0 with pulse modulation laser technology. The study will be including kidney and ureteral stones (a kidney stone located in the tube between the kidney and the bladder) that are 6mm and greater, but less than 20 mm in size undergoing ureteroscopic treatment. High powered lasers are used for "dusting". Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.

Conditions Studied

Kidney Stone Ureteral Stone

Interventions

  • PROCEDURE Dusting without Moses 2.0 Modulation
  • PROCEDURE Dusting with Moses 2.0 Modulation
  • OTHER Moses 2.0 Modulation

Study Locations (1)

Illinois

  • Northwestern Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-06-09
Est. Completion 2026-06-09
Phase NA

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06346483

The ClinicalTrials.gov registry entry for NCT06346483 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 28 other Kidney Stone trials with a reported enrollment target (20% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Kidney Stone appearing as the primary indexed condition, and to 3 interventions - of which Dusting without Moses 2.0 Modulation is the first listed.

NCT06346483 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06346483 about?

NCT06346483 is a clinical study titled "Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off". The purpose of this study is to compare Moses 2.0 pulse modulation technology and the standard high powered Holmium Laser lithotripsy and how it will affect time in the operating room, time using the laser, laser energy, and stone free rates. Currently Moses 2.0 laser technology is FDA approved and...

What is the current status of trial NCT06346483?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-06-09. Estimated completion is 2026-06-09.

What conditions does trial NCT06346483 study?

This clinical trial studies the following conditions: Kidney Stone, Ureteral Stone.

What interventions are being tested in trial NCT06346483?

The interventions under investigation include: Dusting without Moses 2.0 Modulation (PROCEDURE), Dusting with Moses 2.0 Modulation (PROCEDURE), Moses 2.0 Modulation (OTHER).

Who is sponsoring clinical trial NCT06346483?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06346483 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Stone

All registered trials for this condition

Ureteral Stone

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.